Yatsen Holding Ltd (NYSE: YSG) reported a widened net loss of 90.8 million yuan for the second quarter, up from a 19.5 million yuan loss in the same period last year. The New York-listed beauty company’s non-GAAP loss also expanded to 99.4 million yuan, reversing its profitability from the prior year.

The results reflect the company’s aggressive pivot from color cosmetics to skincare, a transition accompanied by rising marketing expenses and contracting gross margins. While revenue grew modestly, the cost structure and competitive pressures in China’s beauty market weighed on bottom-line performance.

Financial Performance

Revenue rose 5.1% year-on-year to 1.14 billion yuan ($168.3 million) in the three months ended June. Despite the top-line growth, profitability deteriorated significantly:

Gross margin fell to 73.9% from 78.3% a year earlier, indicating pricing pressure or higher input costs during the product mix shift. Chairman David Huang attributed the margin compression to sustained investment in brand building, noting that marketing expenses exceeded 70% of revenue. He emphasized that these efforts are raising brand awareness and that existing brands have yet to reach their full potential.

Skincare Drives Growth

Skincare has become Yatsen’s primary growth engine, surpassing its traditional color cosmetics line. Revenue from skincare brands—including Galénic, Dr. Wu, and Eve Lom—jumped 40.4% during the quarter, accounting for more than 70% of total sales. This marks a significant shift from a year earlier, when skincare revenue had just crossed the 50% threshold.

Conversely, revenue from color cosmetics, led by the Perfect Diary brand, fell 35.8%. This decline reflects intensifying competition and growing consumer caution in the crowded Chinese makeup market, where Yatsen previously relied on aggressive digital marketing and celebrity partnerships.

What the Numbers Show

The divergence between skincare and cosmetics performance highlights Yatsen’s structural transformation. With skincare contributing over 70% of revenue but gross margins contracting by 440 basis points, the company is trading short-term profitability for market share in a higher-value segment. The fact that marketing spend exceeds 70% of revenue suggests that customer acquisition costs remain high, potentially limiting near-term margin recovery despite the successful volume shift toward skincare.

Technology and Manufacturing

Yatsen is leveraging AI and biotech research to differentiate its products. At its Guangzhou manufacturing hub—a joint venture with South Korea’s Cosmax—the company uses AI-assisted ingredient discovery, formulation development, and clinical assessment. The facility, which began operations in 2023, spans 78,000 square meters and is billed as Asia’s largest single cosmetics plant.

Key technological initiatives include:

• AI-based molecular docking to identify PDRN efficacy boosters, shortening ingredient discovery from years to months.
• Automated robotic arms and guided vehicles for materials handling and packaging.
• A 3,000-square-meter testing center with instruments valued at more than 10 million yuan, monitoring over 50 quality parameters.

Yatsen has spent more than 770 million yuan on product development since 2022, with R&D expenses representing about 3.3% of revenue in the latest quarter. The company operates research centers in Shanghai, Guangzhou, and Toulouse, France, aiming to apply skincare technologies to color cosmetics through "makeup skintification."

Strategic Outlook

China remains Yatsen’s top priority, though the company is exploring opportunities in Asia and Europe. Chairman David Huang stated that Yatsen is not ruling out acquisitions of assets with strong brand equity and product performance, adhering to its multi-brand strategy vision.

The stock has lost more than three-quarters of its value over the last 52 weeks, erasing gains from a rally in the first half of 2025. Investors will be watching whether Yatsen’s investments in science, AI, and scalable production can deliver durable competitive advantages in China’s fast-changing beauty market.

Yatsen Holding (NYSE: YSG) has provided a sales guidance range for its third fiscal quarter, projecting revenue between $132.437 million and $147.146 million. The company disclosed this outlook without accompanying details on net profit, operating margins, or year-over-year growth comparisons.

The guidance indicates a revenue band with a spread of approximately $14.7 million between the lower and upper estimates. No further financial metrics, including earnings per share or operating expenses, were included in the disclosure.

Guidance Overview

As the source material contains only revenue guidance without comparative prior-period figures or cost data, no analytical observation regarding margin trends or profitability can be derived.